Why the study?
Does cholesterol-lowering therapy reduce the risk for coronary heart disease in the elderly population?
Does cholesterol-lowering therapy reduce the risk for coronary heart disease in the elderly population?
Cholesterol-lowering therapy is beneficial for reducing coronary heart disease risk in the elderly population, similar to younger individuals.
Answers are grounded in this paper and cite their sources.
May support cholesterol-lowering in elderly for CHD prevention; confirms benefit across ages but leaves optimal regimens open.
The incidence of coronary heart disease (CHD) peaks in the elderly population. In secondary and primary prevention trials, cholesterol-lowering therapy reduces risk for CHD in both older and younger participants. This benefit, therefore, can be extended to the elderly.
No takes yet. Share an insight, caveat, or question.
Scott M. Grundy (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: